University of Minnesota Department of Ophthalmology — Minneapolis, Minnesota

University of Minnesota Department of Ophthalmology is a clinical research site located in Minneapolis, Minnesota, United States 55455.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Minnesota Department of Ophthalmology has participated in 2 clinical trials.

Therapeutic areas: Optic Atrophy, Non-arteritic Anterior Ischemic Optic Neuropathy, Retinitis Pigmentosa.

Sponsors: Quark Pharmaceuticals, Second Sight Medical Products.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Minnesota Department of Ophthalmology?

University of Minnesota Department of Ophthalmology has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Minnesota Department of Ophthalmology conducted?

University of Minnesota Department of Ophthalmology has 2 clinical trials on record. Their work covers Optic Atrophy, Non-arteritic Anterior Ischemic Optic Neuropathy, Retinitis Pigmentosa.

Is University of Minnesota Department of Ophthalmology accredited by Crixeo Clinical Trials?

University of Minnesota Department of Ophthalmology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Minnesota Department of Ophthalmology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.